These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29997218)

  • 1. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
    PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.
    Knight JS; Robertson ES
    J Virol; 2004 Feb; 78(4):1981-91. PubMed ID: 14747563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.
    Sun K; Bose D; Singh RK; Pei Y; Robertson ES
    J Virol; 2024 Jul; 98(7):e0054824. PubMed ID: 38864622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
    Saha A; Halder S; Upadhyay SK; Lu J; Kumar P; Murakami M; Cai Q; Robertson ES
    PLoS Pathog; 2011 Feb; 7(2):e1001275. PubMed ID: 21347341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
    Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
    J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.
    Pei Y; Banerjee S; Jha HC; Sun Z; Robertson ES
    PLoS Pathog; 2017 Jul; 13(7):e1006500. PubMed ID: 28738086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.
    Cotter MA; Robertson ES
    Mol Cell Biol; 2000 Aug; 20(15):5722-35. PubMed ID: 10891508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
    Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
    Shukla SK; Jha HC; El-Naccache DW; Robertson ES
    Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.
    Banerjee S; Lu J; Cai Q; Sun Z; Jha HC; Robertson ES
    PLoS Pathog; 2014 Aug; 10(8):e1004304. PubMed ID: 25121590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
    Knight JS; Sharma N; Kalman DE; Robertson ES
    J Virol; 2004 Dec; 78(23):12857-67. PubMed ID: 15542638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.
    Pei Y; Banerjee S; Sun Z; Jha HC; Saha A; Robertson ES
    PLoS Pathog; 2016 Aug; 12(8):e1005844. PubMed ID: 27548379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.
    Choudhuri T; Verma SC; Lan K; Murakami M; Robertson ES
    J Virol; 2007 Jun; 81(12):6718-30. PubMed ID: 17409144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
    Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.